BRCA1- and BRCA2-associated hereditary breast and ovarian cancers are characterized by an increased risk of developing breast cancer in both men and women, as well as ovarian, fallopian tube, and primary peritoneal cancers [1]. This evidence concerns the gene BRCA2 and ovarian cancer.